Tema Oncology ETF (CANC) Institutional Ownership $38.12 0.00 (0.00%) As of 05/22/2026 03:59 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tema Oncology ETF (NASDAQ:CANC)Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$68.35MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$23.24M Get CANC Insider Trade Alerts Want to know when executives and insiders are buying or selling Tema Oncology ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CANC Institutional Buying and Selling by Quarter Tema Oncology ETF Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2026 Roxbury Financial LLC924$34K0.0%N/A0.020% 2/12/2026 Jane Street Group LLC31,696$1.10M0.0%N/A0.794% 2/11/2026 LPL Financial LLC8,018$278K0.0%N/A0.201% 2/5/2026 Thrivent Financial for Lutherans1,461,649$50.75M0.1%+891.1%36.633% 11/17/2025 Flow Traders U.S. LLC21,939$630K0.0%N/A0.786% 11/4/2025 Thrivent Financial for Lutherans147,472$4.23M0.0%-84.6%5.286% 8/26/2025 Thrivent Financial for Lutherans957,475$23.67M0.1%+658.7%36.685% 8/14/2025 Jane Street Group LLC14,104$349K0.0%+59.7%0.540% 5/19/2025Jane Street Group LLC8,829$213K0.0%N/A0.326% 5/16/2025Banque Transatlantique SA1,750$39K0.0%N/A0.065% 2/10/2025Thrivent Financial for Lutherans517,837$13.16M0.0%+29.6%20.307% 11/15/2024Jane Street Group LLC44,311$1.26M0.0%-69.1%2.547% 11/7/2024Thrivent Financial for Lutherans399,509$11.35M0.0%+25.1%22.960% 8/13/2024Thrivent Financial for Lutherans319,376$8.62M0.0%N/A19.010% CANC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CANC shares? During the previous two years, the following institutional investors and hedge funds held shares of Tema Oncology ETF shares: Thrivent Financial for Lutherans ($50.75M), Jane Street Group LLC ($1.10M), Flow Traders U.S. LLC ($630K), LPL Financial LLC ($278K), and Banque Transatlantique SA ($39K), Roxbury Financial LLC ($34K).Learn more on Tema Oncology ETF's institutional investors. Which institutional investors have been buying Tema Oncology ETF's stock? The following institutional investors have purchased Tema Oncology ETF's stock in the last 24 months: Thrivent Financial for Lutherans ($2.66M), Jane Street Group LLC ($45.80K), Flow Traders U.S. LLC ($21.94K), LPL Financial LLC ($8.02K), Banque Transatlantique SA ($1.75K), and Roxbury Financial LLC ($924.00). How much institutional buying is happening at Tema Oncology ETF? Institutional investors have bought a total of 2,213,310 shares in the last 24 months. This purchase volume represents approximately $68.35M in transactions. Which of Tema Oncology ETF's major shareholders have been selling company stock? The following institutional investors have sold Tema Oncology ETF stock in the last 24 months: Thrivent Financial for Lutherans ($810.00K). How much institutional selling is happening at Tema Oncology ETF? Institutional investors have sold a total of 810,003 shares in the last 24 months. This volume of shares sold represents approximately $23.24M in transactions. Related Companies SDG Major Shareholders COPJ Major Shareholders FINX Major Shareholders NZAC Major Shareholders KOID Major Shareholders ELFY Major Shareholders CHGX Major Shareholders EMXF Major Shareholders QQMG Major Shareholders FBOT Major Shareholders This page (NASDAQ:CANC) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
